Versant Capital Management »

Cytek Biosciences shares owned by Versant Capital Management

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5k 435 3.47
2025-06-30 $513 151 3.40
2025-03-31 $3.8k 939 4.01
2024-12-31 $6.7k 1.0k 6.49
2024-09-30 $5.7k 1.0k 5.54
2023-09-30 $1.6k 286 5.52

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Brown Capital Management
State Street Corporation
Millennium Management
Dimensional Fund Advisors
Geode Capital Management
Wellington Management Company
Royce & Associates
Goldman Sachs Group
Morgan Stanley
Charles Schwab Investment Management
AQR Capital Management
Northern Trust

View all funds holding Cytek Biosciences